David Hoffmann
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Ubiquitin and proteasome pathways 1
- Protein Kinase Regulation and GTPase Signaling 1
- Angiogenesis and VEGF in Cancer 1
-
- Galectins and Cancer Biology 1
- Co-authors
- Karl Mechtler (1 shared paper)Kota Yanagitani (1 shared paper)Luiza Deszcz (1 shared paper)Alexander Schleiffer (2 shared papers)Astrid Hagelkrüys (1 shared paper)Fumiyo Ikeda (1 shared paper)Josef Martin Penninger (2 shared papers)Anoop Murthy Kavirayani (1 shared paper)
- Journals
- The EMBO Journal (2 papers)Nature (1 paper)EMBO Molecular Medicine (1 paper)Cancer Research (1 paper)Nature Cancer (1 paper)
- Partner nations
- AustriaCanadaUnited Kingdom
In The Last Decade
David Hoffmann
7 papers receiving 577 citations
Peers
Comparison fields: 5 of 59
- Biological Psychiatry 11
- Oncology 134
- Cancer Research 62
- Immunology 65
- Molecular Biology 173
Countries citing papers authored by David Hoffmann
This map shows the geographic impact of David Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hoffmann more than expected).
Fields of papers citing papers by David Hoffmann
This network shows the impact of papers produced by David Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hoffmann. The network helps show where David Hoffmann may publish in the future.
Co-authors
The 13 scholars most cited alongside David Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 240 | |
| 2 | 2021 | 157 | |
| 3 | 2019 | 91 | |
| 4 | 2021 | 59 | |
| 5 | 2020 | 27 | |
| 6 | 2020 | 11 | |
| 7 | 2025 | 1 |
About David Hoffmann
David Hoffmann is a scholar working on Molecular Biology, Immunology, Cancer Research, Pharmacology and Infectious Diseases, having authored 7 papers that have together received 586 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (2 papers), Ubiquitin and proteasome pathways (1 paper), Apelin-related biomedical research (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Galectins and Cancer Biology (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Biological Psychiatry (11 citations), Oncology (134 citations), Cancer Research (62 citations), Immunology (65 citations) and Molecular Biology (173 citations). David Hoffmann has collaborated with scholars based in Austria, Canada and United Kingdom. Frequent co-authors include Karl Mechtler, Kota Yanagitani, Luiza Deszcz, Alexander Schleiffer, Astrid Hagelkrüys, Fumiyo Ikeda, Josef Martin Penninger, Anoop Murthy Kavirayani, Stefan Mereiter and Masahiro Onji. Their work appears in journals such as The EMBO Journal, Nature, EMBO Molecular Medicine, Cancer Research and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.